AstraZeneca sells 7.7% stake in Moderna for over $1 billion » - IPS BUSINESS SCHOOL

AstraZeneca sells 7.7% stake in Moderna for over $1 billion

AstraZeneca sells 7.7% stake in Moderna for over $1 billion

AstraZeneca Plc has sold its 7.7 percent stake in Moderna Inc for more than $1 billion after the US biotechnology company's shares soared on the back of its coronavirus vaccine breakthrough, The Times reported.

The report added that it was not clear over what period British-based AstraZeneca sold its holding in Moderna.

AstraZeneca and Moderna did not immediately respond to requests for comment.

AstraZeneca is retaining partnership with Moderna on other disease treatments and could sell its AstraZeneca-Oxford University COVID-19 vaccine on a commercial basis in future if the virus becomes endemic, the
report added.

Moderna, whose vaccine is cleared for emergency use against COVID-19 in the United States, said last week it was expecting sales of $18.4 billion from its coronavirus vaccine this year.

Leave a Reply

Your email address will not be published. Required fields are marked *

Enquiry Now
close slider

    Enquire Now






    captcha

    Apply Now
    ×